BBIO : Insider Transactions for Bridgebio Pharma, Inc. | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Bridgebio Pharma, Inc. (BBIO)

$27.13

1.85 (6.38%) as of 4:30 Tue 6/4

Download

Exchange:

N/A

Security Type:

Common

Shares Out:

173,970,000

Market Cap:

4.72(B)

Last Volume:

0

Avg Vol:

0

52 Week Range:

$14 - $43.89

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile BridegeBio Pharma identifies and improves medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Co.'s pipeline are: Acoramidis/AG10/BBP-265, a small molecule transthyretin (TTR) stabilizer for the treatment of TTR amyloidosis; Infigratinib/BBP-831, an oral FGFR1-3 selective tyrosine kinase inhibitor for the treatment of achondroplasia; BBP-631, a preclinical adeno-associated virus gene transfer for the treatment of congenital adrenal hyperplasia; and Encaleret, a small molecule antagonist of the calcium sensing receptor for the treatment of Autosomal Dominant Hypocalcemia Type 1.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	0	113,245	1,769,632	2,886,602
Total Sell Value	$0	$4,697,014	$61,715,300	$73,415,196
Total People Sold	0	3	6	6
Total Sell Transactions	0	6	14	29
End Date	2024-03-07	2023-12-05	2023-06-06	2022-06-06

Adjust Filter Settings

Records found: 292

Page 11 of 12

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

CEO and President

• • –

2020-03-02

4

AS

$31.88

$3,226,883

I/I

(99,953)

2,665,419

-2%

Stephenson Brian C

See Remark

• – –

2020-03-02

4

AS

$31.79

$348,541

D/D

(10,800)

337,516

-2%

Momtazee James C

Director

– • –

2020-02-12

4

A

$0.00

$0

D/D

8,491

8,491

-

See Remarks

• – –

2020-02-11

4

AS

$37.28

$74,564

D/D

(2,000)

9,823

-5%

See Remarks

• – –

2020-02-11

4

OE

$17.00

$34,000

D/D

2,000

11,823

-

Homcy Charles J

Chairman of Pharmaceuticals

• • –

2020-02-10

4

AS

$36.00

$720,000

D/D

(20,000)

1,342,291

-10%

CEO and President

• • –

2020-02-05

4

AS

$34.87

$1,077,390

I/I

(30,893)

2,765,372

-8%

See Remarks

• • –

2020-02-04

4

AS

$34.55

$1,898,387

I/I

(54,951)

2,796,265

-10%

Stephenson Brian C

See Remarks

• – –

2020-02-04

4

AS

$34.52

$171,692

D/D

(4,973)

348,316

-10%

Henderson Michael Thomas

See Remarks

• – –

2020-02-03

4

AS

$34.90

$138,729

D/D

(3,975)

174,287

-17%

See Remarks

• • –

2020-02-03

4

AS

$34.92

$1,193,223

I/I

(34,156)

2,851,216

-17%

Stephenson Brian C

See Remarks

• – –

2020-02-03

4

AS

$34.90

$203,379

D/D

(5,827)

353,289

-17%

Homcy Charles J

Chairman of Pharmaceuticals

• • –

2020-01-14

4

AS

$35.00

$350,000

D/D

(10,000)

1,362,291

0%

Homcy Charles J

Chairman of Pharmaceuticals

• • –

2020-01-14

4

OE

$17.00

$170,000

D/D

10,000

1,372,291

-

See Remarks

• – –

2020-01-08

4

AS

$34.17

$440,211

D/D

(12,807)

9,823

-10%

See Remarks

• – –

2020-01-08

4

OE

$17.00

$170,000

D/D

10,000

22,630

-

See Remarks

• • –

2020-01-03

4

AS

$32.14

$2,702,956

I/I

(83,939)

2,885,372

-13%

Henderson Michael Thomas

See Remarks

• – –

2020-01-03

4

AS

$32.28

$11,575

D/D

(358)

178,262

-13%

Stephenson Brian C

See Remarks

• – –

2020-01-03

4

AS

$31.94

$117,440

D/D

(3,636)

359,116

-13%

See Remarks

• • –

2020-01-02

4

AS

$32.55

$1,199,461

I/I

(36,061)

2,969,311

-7%

Henderson Michael Thomas

See Remarks

• – –

2020-01-02

4

AS

$32.69

$120,286

D/D

(3,617)

178,620

-7%

Stephenson Brian C

See Remarks

• – –

2020-01-02

4

AS

$32.57

$238,243

D/D

(7,164)

362,752

-7%

Kkr Fund Holdings L.p.

– – •

2020-01-01

3

IO

$0.00

$0

I/I

0

36,900,661

-7%

Kkr Management Holdings Corp

• • •

2020-01-01

4

D

$0.00

$0

I/I

(36,900,661)

0

-

Mccormick Frank

Chairman of Oncology

• – –

2019-12-30

4

AS

$35.74

$614,012

D/D

(17,150)

1,261,526

-7%

292 Records found	Previous 10 11 12	Page 11 of 12

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.